Home
About
FAQ
History (1)
Tildrakizumab: A Review of Phase II and III Clinical Trials.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Tildrakizumab: A Review of Phase II and III Clinical Trials.
Kolli SS, Gabros SD, Pona A, Cline A, Feldman SR. Tildrakizumab: A Review of Phase II and III Clinical Trials. Ann Pharmacother. 2019 04; 53(4):413-418.
View in:
PubMed
subject areas
Clinical Trials, Phase II as Topic
Clinical Trials, Phase III as Topic
Dose-Response Relationship, Drug
Humans
Interleukin-23 Subunit p19
Psoriasis
Treatment Outcome
authors with profiles
Steven R. Feldman MD, PhD